VR Logo

Insmed Inc. (INSM) download report


Healthcare | Biotechnology & Pharma Research

Insmed Inc. (INSM) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases.

IPO Date: 01-Jun-2000

Pres, CEO & Chairman: Mr. William H. Lewis J.D., M.B.A.

Chief Financial Officer: Ms. Sara M. Bonstein MBA

Listing: NASDAQ: INSM

Country: United States

Headquarters: Bridgewater, NJ

Website: https://www.insmed.com

Key Facts

Market cap: $2,515.83 Mln

Revenue (TTM): $201.35 Mln

Earnings (TTM): $-437.63 Mln

Cash: $635.12 Mln

Total Debt: $836.29 Mln

Insider's Holding: 2.46%

Liquidity: Low

52 Week range: $16.44 - 34.44

Shares outstanding: 119,517,000

10 Years Aggregate:

  • CFO: $-1,640.39 Mln
  • EBITDA: $-1,799.37 Mln
  • Net Profit: $-1,971.07 Mln

Stock Performance

Time Period Insmed (INSM) S&P BSE Sensex* S&P Small-Cap 600*
YTD-26.91-8.97-18.40
1 month2.00-3.38-8.42
3 months-9.62-7.93-14.06
1 Year-31.200.55-17.64
3 Years-7.6810.416.75
5 Years2.6311.456.18
10 Years20.3612.0510.23
As on 28-Jun-2022 *As on 29-Jun-2022
Year Insmed (INSM) S&P Small-Cap 600 S&P BSE Sensex
2021-18.1725.2721.99
202039.419.5715.75
201982.0120.8614.38
2018-57.72-9.705.87
2017135.6811.7327.91
2016-27.1124.741.95
201517.32-3.36-5.03